When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mainly used to make the site work as you expect it to. The information does not directly identify you but can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to learn more and change our default settings. However, blocking some types of cookies may impact your experience of the site. You can find more information, including a detailed cookie explanation, on our Cookie Policy.
Press Releases & News
-
News
15th Jun 2023
Quibim partners with European Commission to launch EUCAIM, a federated infrastructure for cancer images data in Europe
Read more
-
Press release
27th Jul 2022
Quibim and Microsoft collaborate to develop virtual biopsies with Artificial Intelligence
Read more
-
Press release
25th Mar 2022
INCLIVA y Quibim firman un acuerdo de colaboración para impulsar la investigación oncológica gracias a la Inteligencia Artificial
Read more
-
Press release
25th Mar 2021
Quibim partners with Highlight Therapeutics to advance immunotherapy in melanoma
Read more
-
News
30th Nov 2022
Digital twin for aided detection, diagnosis of prostate cancer and simulation of treatment effects
Read more
-
News
03rd Mar 2021
Quibim Receives FDA 510(k) Clearance for qp-Prostate, a New AI Solution for Prostate MRI Analysis
Read more